FDA-Drug2023-08-09Class II
rocuronium50 mg/5 mL (10 mg/mL), Syringes Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue, Pheonix, AZ, NDC 72196-6010-1.
Hazard
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Sold states
Nationwide in the USA
Affected count
77,554 Syringes.
Manufactured in
2200 S 43rd Ave, N/A, Phoenix, AZ, United States
Products
rocuronium50 mg/5 mL (10 mg/mL), Syringes Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue, Pheonix, AZ, NDC 72196-6010-1.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0947-2023Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief